Models for an Ultraviolet-C Research and Development Consortium
- PMID: 38469448
- PMCID: PMC10112004
- DOI: 10.6028/jres.126.055
Models for an Ultraviolet-C Research and Development Consortium
Abstract
The development of an international, precompetitive, collaborative, ultraviolet (UV) research consortium is discussed as an opportunity to lay the groundwork for a new UV commercial industry and the supply chain to support this industry. History has demonstrated that consortia can offer promising approaches to solve many common, current industry challenges, such as the paucity of data regarding the doses of ultraviolet-C (UV-C, 200 nm to 280 nm) radiation necessary to achieve the desired reductions in healthcare pathogens and the ability of mobile disinfection devices to deliver adequate doses to the different types of surfaces in a whole-room environment. Standard methods for testing are only in the initial stages of development, making it difficult to choose a specific UV-C device for a healthcare application. Currently, the public interest in UV-C disinfection applications is elevated due to the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the respiratory coronavirus disease 19 (COVID-19). By channeling the expertise of different UV industry stakeholder sectors into a unified international consortium, innovation in UV measurements and data could be developed to support test methods and standards development for UV healthcare equipment. As discussed in this paper, several successful examples of consortia are applicable to the UV industry to help solve these types of common problems. It is anticipated that a consortium for the industry could lead to UV applications for disinfection becoming globally prolific and commonplace in residential, work, business, and school settings as well as in transportation (bus, rail, air, ship) environments. Aggressive elimination of infectious agents by UV-C technologies would also help to reduce the evolution of antibiotic-resistant bacteria.
Keywords: UV-C; capacity building; collaboration; disinfection; hospitals; innovation; market growth; partnerships; pathogens; public health; ultraviolet; viruses.
Figures









Similar articles
-
Ultraviolet Radiation Technologies and Healthcare-Associated Infections: Standards and Metrology Needs.J Res Natl Inst Stand Technol. 2021 Aug 20;126:126014. doi: 10.6028/jres.126.014. eCollection 2021. J Res Natl Inst Stand Technol. 2021. PMID: 38469449 Free PMC article.
-
Innovative Approaches to Combat Healthcare-Associated Infections Using Efficacy Standards Developed Through Industry and Federal Collaboration.Proc SPIE Int Soc Opt Eng. 2018;10730:10.1117/12.2500431. doi: 10.1117/12.2500431. Proc SPIE Int Soc Opt Eng. 2018. PMID: 31092964 Free PMC article.
-
Inactivation of Pathogens in Air Using Ultraviolet Direct Irradiation Below Exposure Limits.J Res Natl Inst Stand Technol. 2022 Mar 1;126:126052. doi: 10.6028/jres.126.052. eCollection 2021. J Res Natl Inst Stand Technol. 2022. PMID: 38469440 Free PMC article.
-
Understanding ultraviolet light surface decontamination in hospital rooms: A primer.Infect Control Hosp Epidemiol. 2019 Sep;40(9):1030-1035. doi: 10.1017/ice.2019.161. Epub 2019 Jun 18. Infect Control Hosp Epidemiol. 2019. PMID: 31210119 Review.
-
A Critical Review on Ultraviolet Disinfection Systems against COVID-19 Outbreak: Applicability, Validation, and Safety Considerations.ACS Photonics. 2020 Oct 14;7(11):2941-2951. doi: 10.1021/acsphotonics.0c01245. eCollection 2020 Nov 18. ACS Photonics. 2020. PMID: 37556269 Review.
Cited by
-
Ultraviolet Radiation Technologies and Healthcare-Associated Infections: Standards and Metrology Needs.J Res Natl Inst Stand Technol. 2021 Aug 20;126:126014. doi: 10.6028/jres.126.014. eCollection 2021. J Res Natl Inst Stand Technol. 2021. PMID: 38469449 Free PMC article.
-
Wind of change: Better air for microbial environmental control.Case Stud Chem Environ Eng. 2022 Dec;6:100240. doi: 10.1016/j.cscee.2022.100240. Epub 2022 Jul 31. Case Stud Chem Environ Eng. 2022. PMID: 37520926 Free PMC article.
References
-
- Anderson DJ, Chen LF, Weber DJ, Moehring RW, Lewis SL, Triplett PF, Blocker M, Becherer P, Schwab JC, Knelson LP, Lokhnygina Y, Rutala WA, Kanamori H, Gergen MF, Sexton DJ (2017) Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection study): A cluster-randomised, multicentre, crossover study. The Lancet 389(20071):805–814. - PMC - PubMed
-
- Anderson DJ, Moehring RW, Weber DJ, Lewis SS, Chen LF, Schwab JC, Becherer P, Blocker M, Triplett PF, Knelson LP, Lokhnygina Y, Rutala WA, Sexton DJ (2018) Effectiveness of targeted enhanced terminal room disinfection on hospital-wide acquisition and infection with multidrug-resistant organisms and Clostridium difficile: A secondary analysis of a multicentre cluster randomised controlled trial with crossover design (BETR Disinfection). The Lancet Infectious Diseases 18(8):845–853. - PMC - PubMed
-
- Boyce JM, Donskey CJ (2019) Understanding ultraviolet light surface decontamination in hospital rooms: A primer. Infection Control and Hospital Epidemiology 40(9):1030–1035. - PubMed
-
- Raeiszadeh M, Adeli B (2020) A critical review on ultraviolet disinfection systems against COVID-19 outbreak: Applicability, validation, and safety considerations. ACS Photonics 7(11):2941–2951. - PubMed
-
- Poster DL, Miller CC, Obeng Y, Postek MT, Cowan TE, Martinello RA (2018) Innovative approaches to combat healthcare associated infections using efficacy standards developed through industry and federal collaboration. Proceedings SPIE—Nanoengineering: Fabrication, Properties, Optics, and Devices XV 10730:107301L. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous